Search results
Kathleen Gallagher: We remain asleep at the wheel while coastal interests take our money, talent,...
Gannett via AOL· 5 days agoThis is the moment. Industrial robots, LiDAR, solar panels, genome sequencing and other “picks and shovels” for building deep tech companies are better and cheaper than a decade ago,
Quest Diagnostics' (DGX) New Buyout Ramps Up Cancer Diagnosis
Zacks via Yahoo Finance· 1 day agoQuest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption...
Wahed Invest LLC Acquires 153 Shares of Illumina, Inc. (NASDAQ:ILMN)
ETF DAILY NEWS· 1 day agoWahed Invest LLC grew its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 6.0% during the fourth quarter, according to the company in its most recent filing ...
DNA Links Man To Decades-Old Sex Offenses Across Fairfax County, Police Say
Daily Voice· 6 days agoThe recovery of DNA evidence has linked a Loudoun County man to unsolved sex offenses dating back to...
Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership
Benzinga· 6 days agoCutting-edge technologies with potential to transform molecular biology Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, and Takara Bio USA, Inc.
Illumina's Options: A Look at What the Big Money is Thinking - Illumina (NASDAQ:ILMN)
Benzinga· 2 days agoThe company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole ...
Wellcome Sanger Benchmarking Study Highlights Suitable Enzymes for NGS Library Amplification
GenomeWeb News· 5 days agoResearchers from the Wellcome Sanger Institute have benchmarked over 20 high-fidelity enzymes for next-generation sequencing library amplification, shedding light on the best ...
DNA says you’re related to a Viking, a medieval German Jew or a 1700s enslaved African? What a...
San Francisco Chronicle· 1 day ago(The Conversation is an independent and nonprofit source of news, analysis and commentary...
Illumina (NASDAQ:ILMN) Shares Down 2.7% on Analyst Downgrade
ETF DAILY NEWS· 6 days agoIllumina, Inc. (NASDAQ:ILMN – Get Free Report) traded down 2.7% during trading on Wednesday after Evercore ISI lowered their price target on the stock from $195.00 to $175.00. Evercore ISI currently ...
Illumina (NASDAQ:ILMN) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 4 days agoStockNews.com began coverage on shares of Illumina (NASDAQ:ILMN – Free Report) in a research note released on Friday morning. The firm issued a buy rating on the life sciences company ...